Click Here to return To Results

 

Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke Stroke 32:861-865, Katzan,I.L.,et al, 2001 See this aricle in Pubmed Article Abstract Intravenous tPA was administered by 46.9% of responding neurologists. Almost 30% (29.9%) of surveyed neurologists were "very convinced" of its efficacy, whereas 61.6% were "very concerned" about the risk of intracranial hemorrhage. Only ha lf of the respondents believed their institutions could meet all NINDS-recommended stroke-evaluation time targets. Neurologists' enthusiasm for the efficacy of intravenous tPA is tempered by their concern about intracranial hemorrhage. Institutional rea diness for evaluating acute stroke patients is not optimized.

Related Tags

(click to filter results - removes previous filter) cerebrovascular accident,acute management of cerebrovascular accident,thrombolytic agents in treatment fibrinolytic agents neurologic practice practice guidelines tissue plasminogen activator,intravenous treatment of neurologic disorder

Click Here to return To Results